Invention Grant
- Patent Title: 9-substituted minocycline compounds
- Patent Title (中): 9-取代的米诺环素化合物
-
Application No.: US10839023Application Date: 2004-05-04
-
Publication No.: US08048867B2Publication Date: 2011-11-01
- Inventor: Mark L. Nelson , Roger Frechette , Peter Viski , Mohamed Y. Ismail , Todd Bowser , Jimmy Dumornay , Glen Rennie , Gui Liu , Darrell J. Koza , Paul Sheahan , Karen Stapleton , Paul Hawkins , Beena Bhatia , Atul K. Verma , Laura McIntyre , Tadeusz Warchol , David Messersmith
- Applicant: Mark L. Nelson , Roger Frechette , Peter Viski , Mohamed Y. Ismail , Todd Bowser , Jimmy Dumornay , Glen Rennie , Gui Liu , Darrell J. Koza , Paul Sheahan , Karen Stapleton , Paul Hawkins , Beena Bhatia , Atul K. Verma , Laura McIntyre , Tadeusz Warchol , David Messersmith
- Applicant Address: US MA Medford US MA Boston
- Assignee: Trustees of Tufts College,Paratek Pharmaceuticals, Inc.
- Current Assignee: Trustees of Tufts College,Paratek Pharmaceuticals, Inc.
- Current Assignee Address: US MA Medford US MA Boston
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Heidi A. Erlacher
- Main IPC: A61K31/59
- IPC: A61K31/59 ; C07C401/00
Abstract:
The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20040214801A1 9-Substituted minocycline compounds Public/Granted day:2004-10-28
Information query
